Fact CheckerSign in

NCT05495997Completed

Cognitive Training in Parkinson's Disease

Effects of Cognitive Training on Everyday Cognitive and Brain Function in Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 11 Aug 2025

Brief summary (registry, in English)

The purpose of this research study is to determine whether cognitive training will improve cognitive and brain functions in people with Parkinson's Disease (PD) during activities of daily living using cognitive evaluations and magnetic resonance imaging (MRI).

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
8 Aug 2022
Start date
13 Jan 2023
Primary completion date
18 Sept 2024
Lead sponsor
Yale University
NCT number
NCT05495997

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 13 Jan 2023 to the primary completion date, 18 Sept 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Metallic surgical implants or traumatically implanted metallic foreign bodies

Other illness

  • History of a neurological disorder such as a brain tumor, stroke, central nervous system infection, multiple sclerosis, movement disorder (other than PD), or seizures
  • History of schizophrenia, bipolar disorder, attention deficit disorder, or obsessive-compulsive disorder
  • History of head injury with loss of consciousness longer than a few minutes
  • Dementia at screening (Montreal Cognitive Assessment score \< 21/30)
  • Cognitive problems in activities of daily living suggestive of more than mild cognitive impairment (PD Cognitive Functional Rating Scale \> 4)
  • Mild cognitive impairment according to the Movement Disorders Society (MDS) Level II comprehensive assessment criteria (\> 1.5 standard deviations below the norm in two tests in a single cognitive domain or in one test in two separate cognitive domains, with the exception that the executive domain scores can be up to 2 standard deviations below the norm)

Other

  • Non-English speaking
  • Pregnancy
  • Breastfeeding
  • Excessive alcohol consumption (\> 7 drinks per week for women, \> 14 drinks per week for men) or illicit substance use
  • Inability to lie flat for about an hour in the MRI scanner
  • Discomfort being in small, enclosed spaces
  • Hoehn \& Yahr stage \> 3 (i.e., able to stand and walk, but not fully independent)
  • Focal neurological findings on exam that suggest cerebral pathology other than that associated with parkinsonism
  • Motor symptoms that could potentially introduce too much motion artifact in the imaging data (e.g., MDS-Unified PD Rating Scale resting tremor score \> 2 in limbs, head/chin tremor, or more than mild dyskinesia by history or exam)

Who the study is looking for

  • Diagnosis of idiopathic PD
  • Age ≥ 40 years
  • Expected to be on a stable dopaminergic medication regimen throughout the study period

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Yale School of Medicine
Coordinator of this site? Confirm its status
New HavenUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.